Pair Name | Beta-Ionone, Sorafenib | ||
Phytochemical Name | Beta-Ionone (PubChem CID: 638014 ) | ||
Anticancer drug Name | Sorafenib (PubChem CID: 216239 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Beta-Ionone, Sorafenib | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Inhibition-->Cell migration | |||
Gene Regulation | Down-regulation | Expression | MMP2 | hsa4313 |
Down-regulation | Expression | MMP9 | hsa4318 | |
Down-regulation | Expression | PTK2 | hsa5747 | |
Down-regulation | Expression | RAC1 | hsa5879 | |
Down-regulation | Expression | RHO | hsa6010 | |
Up-regulation | Expression | TIMP1 | hsa7076 | |
Up-regulation | Expression | TIMP2 | hsa7077 | |
In Vitro Model | SK-HEP-1 | Liver and intrahepatic bile duct epithelial neoplasm | Homo sapiens (Human) | CVCL_0525 |
Result | SF enhanced the suppressing effect of BI (1-50 μM) on the viability of SK-Hep-1 cells, but not on murine hepatic BNL CL.2 cells, indicating the selective cytotoxicity of this combination on tumor cells. The combination of SF and BI could be a potential therapeutic strategy against human hepatoma cells. |
No. | Title | Href |
---|---|---|
1 | Synergistic effects of the combination of β-ionone and sorafenib on metastasis of human hepatoma SK-Hep-1 cells. Invest New Drugs. 2012;30(4):1449-1459. doi:10.1007/s10637-011-9727-0 | Click |